Healthcare
The healthcare sector remains one of the fastest growing parts of the global economy and one of the biggest challenges facing policy makers and the private sector. The cost of healthcare continues to outpace inflation in virtually every country in the world, and efforts at reform and cost containment make operating a commercial venture in the sector a continually dynamic enterprise. Despite the challenges, though, the sector holds great opportunities driven by the aging population in developed countries, increasing demand for sophisticated therapies and care systems in developing countries, rapidly advancing health technologies.
The healthcare category covers the array of market products and services that form the environment in which clinical care is provided, including the financial side of medical markets from private healthcare financing (insurance, managed care, and reimbursement schemes) to public regulation and policy (government programs and subsidies). It also covers issues in care delivery and settings (hospitals, clinics, long-term care facilities, personnel, improvement initiatives, and prevention/wellness programs) and technological product categories that will impact the entire system (hospital information systems, telemedicine, and electronic medical records [EMR]).
The healthcare category covers the array of market products and services that form the environment in which clinical care is provided, including the financial side of medical markets from private healthcare financing (insurance, managed care, and reimbursement schemes) to public regulation and policy (government programs and subsidies). It also covers issues in care delivery and settings (hospitals, clinics, long-term care facilities, personnel, improvement initiatives, and prevention/wellness programs) and technological product categories that will impact the entire system (hospital information systems, telemedicine, and electronic medical records [EMR]).
Page 13/13
Bupa - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Bupa - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Bayer Healthcare Pharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Stryker Corporation - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Stryker Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Amgen, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Amgen, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Kyowa Hakko Kirin Co., Ltd. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Kyowa Hakko Kirin Co., Ltd. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Krka, d. d., Novo mesto - Strategy and SWOT Report
December 2012 · MarketLine
Krka, d. d., Novo mesto - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Molina Healthcare, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Molina Healthcare, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Universal Health Services, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Universal Health Services, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Boehringer Ingelheim GmbH - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Boehringer Ingelheim GmbH - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Highmark Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Highmark Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Align Technology, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Align Technology, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
LCA-Vision Inc. - Strategy and SWOT Report
December 2012 · MarketLine
LCA-Vision Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Virbac Corporation - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Virbac Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Crucell N.V. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Crucell N.V. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Health Care Service Corporation - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Health Care Service Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Pharmaceuticals: Global Industry Almanac
December 2012 · MarketLine
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 2.199,00
Pharmaceuticals: Global Industry Guide
December 2012 · MarketLine
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 1.099,00
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
November 2012 · MarketLine
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on ... € 749,00
Pharmaceuticals - Global Group of Eight (G8) Industry Guide
November 2012 · MarketLine
Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and ... € 1.099,00
Pharmaceuticals - North America (NAFTA) Industry Guide
November 2012 · MarketLine
Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. € 599,00
Pharmaceuticals - Scandinavia Industry Guide
November 2012 · MarketLine
Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data ... € 599,00
Pharmaceuticals - Top 5 Emerging Markets Industry Guide
November 2012 · MarketLine
Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). € 749,00
Pharmaceuticals: Global Industry Almanac
November 2012 · MarketLine
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 2.199,00
Pharmaceuticals: Global Industry Guide
November 2012 · MarketLine
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends. € 1.099,00
Options

